FNY Investment Advisers’s Cano Health, Inc. CANO Stock Holding History

FNY Investment Advisers’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$1K	–	1014
2021 Q1	$1K	Buy	+1	New	+$1.42K	﹤0.01%	732

Other funds holding CANO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FNY Investment Advisers's CANO Position: Q4 2023 in Review

FNY Investment Advisers sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 30 shares.

FNY Investment Advisers first reported a position in CANO in Q3 2020 and held it in 11 quarters. The position peaked at $643K in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

FNY Investment Advisers reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
FNY Investment Advisers sold 30 Cano Health, Inc. shares in Q4 2023.
FNY Investment Advisers first reported a position in Cano Health, Inc. in Q3 2020 and held it in 11 quarters.
FNY Investment Advisers's Cano Health, Inc. position peaked at $643K in Q3 2022.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on FNY Investment Advisers's 13F filing for Q4 2023, filed 12 Jan 2024.